Patent details
300974 Product Name: Binimetinib, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout of solvaat
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
- Publication number:
- 300974
- Type:
- Certificate
- SPC Type:
- Medical
- Basic Patent Number:
- EP1482932
- Status:
- SPC in force
- Application number:
- 300974
- Procedural language:
- Dutch
- First Applicant Residence Country:
- United States of America (US)
Paediatric Extension
- SPC Extension Filing Date:
- 20/02/2026
- SPC Extension Agent/Owner Name:
- AstraZeneca AB , Array BioPharma Inc. , ir. B.Ch. Ledeboer c.s
- SPC Extension Status:
- Extension Granted
- SPC Extension Grant Date:
- 26/03/2026
- SPC Extension Request Refusal Date:
- SPC Extension Revocation Date:
Marketing Authorization
- Marketing Authorization Number:
- EU/1/18/1315
- Marketing Authorization Type:
- EEA
- Marketing Authorization Date:
- 24/09/2018
- Marketing Authorization Country:
- European Union (EU)
Dates
- Filing date:
- 15/03/2019
- First Marketing Authorization date:
- 24/09/2018
- Grant date:
- 06/04/2022
- Activation date:
- 13/03/2023
- Lapsed By Non Payment Annual Fee Date:
- Renunciation Date:
- NullificationDate:
- Registration date:
- 21/03/2019
- SPC/SPC Extension Expiration Date:
- 12/09/2028
- Lapsed By Expiration Date:
- Withdrawal date:
- Revocation Date:
- Invalidity Date:
- Withdrawal Market Authorization Date:
- Refusal Date:
Applicant/holder
- From:
- 28/06/2019
- Name:
- AstraZeneca AB
- Address:
- Västra Mälarehamnen 9, 15185, Södertälje, Sweden (SE)
- From:
- 28/06/2019
- Name:
- Array BioPharma Inc.
- Address:
- 3200 Walnut Street, 80301, Boulder, CO, United States of America (US)
Historical Applicant/holder
- From:
- 15/03/2019
- To:
- 28/06/2019
- Name:
- Array Biopharma, Inc.
- Address:
- 3200 Walnut Street, 80301, Boulder, Colorado, United States of America (US)
- From:
- 15/03/2019
- To:
- 28/06/2019
- Name:
- AstraZeneca AB
- Address:
- Västra Mälarehamnen 9, 15185, Södertälje, Sweden (SE)
Agent
1
- Name:
- ir. B.Ch. Ledeboer c.s
- From:
- 28/07/2025
- Address:
- V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
- To:
2
- Name:
- ir. H.A. Witmans c.s.
- From:
- 15/03/2019
- Address:
- V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
- To:
- 28/07/2025
Publication
Bulletin
1
- Bulletin Heading:
- SPC
- Journal edition number:
- 08/26
- Publication date:
- 25/02/2026
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
2
- Bulletin Heading:
- SPC
- Journal edition number:
- 11/23
- Publication date:
- 15/03/2023
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
3
- Bulletin Heading:
- SPC
- Journal edition number:
- 14/22
- Publication date:
- 06/04/2022
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
4
- Bulletin Heading:
- CO
- Journal edition number:
- 28/19
- Publication date:
- 10/07/2019
- Description:
- Changes in the Netherlands Patent Register
5
- Bulletin Heading:
- SPC
- Journal edition number:
- 13/19
- Publication date:
- 27/03/2019
- Description:
- Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Change of owner(s) name
- Deed Number:
- RC201901285B
- Date Registered:
- 28/06/2019
- License Effective Date:
- License Expiration Date:
- Scope of License:
- Deed Filer:
- ir. H.A. Witmans c.s.
- Journal Edition Number:
- Text:
- Deed Status:
- Country Code:
- Updated License Number:
- Terminated License Number:
Added Owner(s)
1
- Name:
- AstraZeneca AB
- Address:
- Västra Mälarehamnen 9, 15185, Södertälje, Sweden (SE)
2
- Name:
- Array BioPharma Inc.
- Address:
- 3200 Walnut Street, 80301, Boulder, CO, United States of America (US)
Changed Pledgee
- Name:
- Address:
Removed Usufructuary
- Name:
- Address:
Added Usufructuary
- Name:
- Address:
Changed Usufructuary
- Name:
- Address:
Annual Fee
- Annual Fee(s) Due Date:
- 31/03/2027
- Annual Fee Number:
- 25
- Annual Fee Amount:
- 2400 Euro
- Last Annual Payment Date:
- 19/12/2025
- Last Annual Fee Paid Number:
- 24
- Last Annual Fee Paid Amount:
- 2200 Euro
- Payer:
- Master Data Center
| Filing date | Document type | Document Description | Number of pages | File Type | ||
|---|---|---|---|---|---|---|
| 26/03/2026 | Certificate | Certificate | 1 | /4/0/4/8/8/0800388404/docs/300974_20_spcxcertificate20260326082838372.pdf | ||
| 26/03/2026 | Outgoing Correspondence | Decision extension duration | 1 | /4/0/4/8/8/0800388404/docs/300974_21_300974701887l504c.pdf | ||
| 23/02/2026 | Outgoing Correspondence | Confirmation receipt request for extension | 2 | /4/0/4/8/8/0800388404/docs/300974_11_300974697026l505.pdf | ||
| 20/02/2026 | SPC Documents | Annex SPC | 1 | /4/0/4/8/8/0800388404/docs/300974_12_supplprotectioncertificate20260223112530489.pdf | ||
| 20/02/2026 | SPC Documents | Annex SPC | 3 | /4/0/4/8/8/0800388404/docs/300974_13_supplprotectioncertificate20260223112705265.pdf | ||
| 20/02/2026 | SPC Documents | Annex SPC | 22 | /4/0/4/8/8/0800388404/docs/300974_14_supplprotectioncertificate20260223112727169.pdf | ||
| 20/02/2026 | SPC Documents | Annex SPC | 4 | /4/0/4/8/8/0800388404/docs/300974_15_supplprotectioncertificate20260223112331243.pdf | ||
| 20/02/2026 | SPC Documents | Summary of the characteristics of the product | 27 | /4/0/4/8/8/0800388404/docs/300974_16_supplprotectioncertificate20260223112355099.pdf | ||
| 20/02/2026 | SPC Documents | Annex SPC | 2 | /4/0/4/8/8/0800388404/docs/300974_17_supplprotectioncertificate20260223112433145.pdf | ||
| 20/02/2026 | SPC Documents | Annex SPC | 17 | /4/0/4/8/8/0800388404/docs/300974_18_supplprotectioncertificate20260223112458595.pdf | ||
| 20/02/2026 | Application Form | First filed application form | 3 | /4/0/4/8/8/0800388404/docs/300974_19_applicationform20260223112029779.pdf | ||
| 06/04/2022 | Outgoing Correspondence | Decision grant | 1 | /4/0/4/8/8/0800388404/docs/300974_9_472475l504a.pdf | ||
| 06/04/2022 | Certificate | Certificate | 1 | /4/0/4/8/8/0800388404/docs/300974_10_spcmedcertificate20220406085142961.pdf | ||
| 25/03/2022 | Incoming Correspondence Paper | Incoming Correspondence Paper | 2 | /4/0/4/8/8/0800388404/docs/300974_0_incomingcorrespondencepaper20220325035739590.pdf | ||
| 12/01/2022 | Outgoing Correspondence | Letter to applicant | 2 | /4/0/4/8/8/0800388404/docs/300974_4_455605l173.pdf | ||
| 21/03/2019 | Outgoing Correspondence | Confirmation receipt request | 1 | /4/0/4/8/8/0800388404/docs/300974_8_260746l174.pdf | ||
| 15/03/2019 | SPC Documents | Marketing Authorization SPC | 3 | /4/0/4/8/8/0800388404/docs/300974_1_supplprotectioncertificate20190320034727765.pdf | ||
| 15/03/2019 | SPC Documents | Summary of the characteristics of the product | 27 | /4/0/4/8/8/0800388404/docs/300974_2_supplprotectioncertificate20190320034727833.pdf | ||
| 15/03/2019 | SPC Documents | Annex SPC | 14 | /4/0/4/8/8/0800388404/docs/300974_3_supplprotectioncertificate20190320034727954.pdf | ||
| 15/03/2019 | Application Form | First filed application form | 3 | /4/0/4/8/8/0800388404/docs/300974_5_applicationform20190320034727555.pdf | ||
| 15/03/2019 | SPC Documents | Accompanying letter SPC | 1 | /4/0/4/8/8/0800388404/docs/300974_6_supplprotectioncertificate20200602040025596.pdf | ||
| 15/03/2019 | SPC Documents | Annex SPC | 2 | /4/0/4/8/8/0800388404/docs/300974_7_supplprotectioncertificate20190320034727892.pdf |